SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Mayne Pharma unit Myx settles US Imvexxy patent case with Sun Pharma, entry set 21 Oct 2032

Myx settled US patent litigation regarding Imvexxy with Sun Pharma. The generic Imvexxy market entry date is set for 21 October 2032; settlement does not include financial payment or upfront monetary consideration.

MYX.AX

Sept 30 (Reuters) — Mayne Pharma Group Ltd: Myx Settles Us Patent Litigation Re Imvexxy With Sun Pharma Generic Imvexxy Agreed Market Entry Date Set For 21 October 2032 Settlement Does Not Include Financial Payment Or Upfront Monetary Consideration Further company coverage: MYX.AX (Reuters.Briefs@thomsonreuters.com;)

Related stories